TrialPloS one2021

A randomised trial examining inflammatory signaling in acutely induced hyperinsulinemia and hyperlipidemia in normal weight women-the reprometabolic syndrome.

Andrew Tannous et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.